Health CanadaGeneral Alert
Archived - Notice to Hospitals - Increased mortality and risk of serious adverse...
Published: December 22, 2006Recall ID: 24210Category: generalCountry: Canada
Product Description & Identification
Archived - Notice to Hospitals - Increased mortality and risk of serious adverse events when prophylactic heparin is abruptly discontinued in patients to be started on Xigris [drotrecogin alfa (activated)] for severe sepsis
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24210 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/archived-notice-hospitals-increased-mortality-and-risk-serious-adverse-events-when |
| Title | Archived - Notice to Hospitals - Increased mortality and risk of serious adverse events when prophylactic heparin is abruptly discontinued in patients to be started on Xigris [drotrecogin alfa (activated)] for severe sepsis |
| Archived | 1 |
| Category | Biologic or vaccine |
| Last updated | 2006-12-22 |
| Organization | Marketed health products |